The ILSI Europe Probiotics Task Force in association with the International Dairy Foundation (IDF) are hosting this workshop with the aim to assess the physiological efficacy of probiotics. The results of this work could guide the scientific substantiation of health claims on probiotics.
Aim and objectives
The overall aim of this workshop is to review a "good practice" document prepared by an ILSI Europe Probiotics Expert Group. They have evaluated the existing evidence related to the effect of probiotics in prevention or treatment of IBD/IBS, allergy, risk of infections and metabolism. With the aim of defining guidelines for further human trials in these areas. This document will build on the work done in PASSCLAIM - Gut Health and immunity Expert Group, on work of the ILSI Europe Nutrition and Immunity in Man Task Force and on existing FAO/WHO guidelines.
To see the programme of the workshop, click here.
To download the report of the workshop, click here.
Welcome and introduction to ILSI Europe and the Probiotics Task Force (Nico van Belzen)
Opening and objectives of the workshop (Ger Rijkers)
Presentation of ISO/IDF collaborative work (Sandra Tuijtelaars)
Strain and species identification (Knut Heller)
Antibiotic susceptibility (Morten Danielsen)
Probiotics and IBS/IBD (Fernando Azpiroz)
Probiotics and allergy (Bengt Björkstén)
Probiotics and metabolism (Furio Brighenti)
Probiotics and the prevention of risk of infection (Hania Szajewska)
Probiotics: current knowledge of health benefits and future perspectives (Seppo Salminen)
For more information, please contact: email@example.com